Insider Trading & Ownership of Kevin Tang

Location
San Diego, CA
Summary
The estimated net worth of Kevin Tang is at least $152,199,145 dollars as of 05 Aug 2025. Kevin Tang is the Director of Aurinia Pharmaceuticals Inc. and owns shares of Aurinia Pharmaceuticals Inc. (AUPH) stock worth about $132.33M. Kevin Tang is the Chief Executive Officer, Director, 10%+ Owner of Odonate Therapeutics, Inc. and owns shares of Odonate Therapeutics, Inc. stock worth about $19.85M. Kevin Tang is the Director, 10%+ Owner of Jounce Therapeutics, Inc. and owns shares of Jounce Therapeutics, Inc. stock worth about $18.5K.
Signature
Kevin Tang
All Insider Reports
All Insider Reports

Notify me when Kevin Tang files a new Insider Trading report.

⭐ Subscribe ⭐

Ownership of Kevin Tang

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
AUPH Aurinia Pharmaceuticals Inc. Director $132,328,560 +$26,303,126 +25% 01 Aug 2025
ODTC Odonate Therapeutics, Inc. Chief Executive Officer, Director, 10%+ Owner $19,852,085 17 Nov 2021
JNCE Jounce Therapeutics, Inc. Director, 10%+ Owner $18,500 03 May 2023
RAIN Rain Oncology Inc. 10%+ Owner $0 26 Jan 2024
OMIC Singular Genomics Systems, Inc. 10%+ Owner $0 21 Feb 2025
TCRR TCR2 THERAPEUTICS INC. 10%+ Owner $0 01 Jun 2023
APVO Aptevo Therapeutics Inc. Exit Filing 23 Nov 2021
LJPC LA JOLLA PHARMACEUTICAL CO Director, 10%+ Owner 22 Aug 2022

Insider Transactions Reported by Kevin Tang:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.